Skip to content

A study to evaluate effect of test food on whole body endurance improvement and fatigue inhibition.

A study to evaluate effect of test food on whole body endurance improvement and fatigue inhibition. - A study to evaluate effect of test food on whole body endurance improvement and fatigue inhibition.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000037267
Enrollment
90
Registered
2019-07-12
Start date
2019-07-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Intake four tablets of test food per one day for nine weeks. Intake four tablets of test food per one day for nine weeks.

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1)Males aged 20-49 years at a time of obtaining informed consent. 2)Subjects who have exercise habits (over 30 minutes at once) once or twice a week. 3)Subjects who can continue with the exercise habits. 4)Subjects who don't take prohibited foods whthin one week before informed consent and can keep it during test period. 5)Subjects who show understanding of the clinical study procedures and agreement with participating this study by written informed consent.

Exclusion criteria

Exclusion criteria: 1) Smokers except subjects who has not been smoking more than one year. 2) From the background questionnaire at preliminary test, subjects who defecate less than and equal to 5 times in a week, who have weakness in their digestive organ, and/or who easily have diarrhea. 3) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ). 4) Subjects who have excessive alcohol intake. 5) Subjects who have extremely irregular dietary habits, have midnight work or irregular shift work. 6) Subjects who have allergy to medicines or foods. 7) Subjects who are participating the other clinical test, were participating it within the past 4 weeks, or are going to participate it. 8) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 9) Subjects who donated over 400mL blood and/or blood components within the last three month to the current study. 10) Subjects who are going to be collected over 1200mL blood and/or blood components which is collected whithin the last 12 month and at this study 11) Subjects judged as unsuitable for the study by the principal or attending investigator.

Design outcomes

Primary

MeasureTime frame
*Maximum oxygen uptake *Visual analog scale questionnaire on fatigue feeling

Secondary

MeasureTime frame
*Rate of perceived exertion *Exercise performance *PWC@75%HRmax *Heart beat number on exercise *Blood biochemical parameters *IL-6 *Growth hormone *Glucagon *Free fatty acid *Microbiota of gut *Blood metabolome analysis *Muscle mass *Body fat mass *SF-8 questionnaire *Incidence rate of adverse events and side effects

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC Company Limited Planning & Sales Department

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026